Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof

Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof

US Patent 6060257 · Granted May 9, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reversible protein multimers, methods for their production and use2025
Anti-GARP protein2022
Nucleic acids encoding GARP-TGF-beta 1 antibodies2020
Method of screening for anti-GARP antibodies2020
GARP-TGF-β 1 IGG antibodies2020
Antibody against a complex between human GARP and latent TGF-β2020
GARP-TGF-beta 1 antibodies2019
Reversible protein multimers, methods for their production and use2018
Method for inhibiting the immune suppressive function of human T regulatory cell2018
Method for modulating activity of T lymphocytes2015
Method for modulating activity of T lymphocytes2015
Tumour rejection antigens2013